Detail akcie Hologic Inc online

Business Summary: Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
Financial Summary: BRIEF: For the six months ended 29 March 2025, Hologic Inc revenues remained flat at $2.03B. Net income decreased 56% to $183.6M. Revenues reflect Diagnostics segment increase of 3% to $924.2M, GYN Surgical segment increase of 3% to $328.8M, Europe segment increase of 6% to $295.4M, also reflect Breast Health segment decrease of 5% to $725.3M, Skeltal Health segment decrease of 7% to $48.8M, United States segment decrease of 1% to $1.5B.